432 related articles for article (PubMed ID: 35808928)
21. Accuracy of FibroScan in analysis of liver fibrosis in patients with concomitant chronic Hepatitis B and nonalcoholic fatty liver disease.
Li Q; Huang C; Xu W; Hu Q; Chen L
Medicine (Baltimore); 2020 Jun; 99(23):e20616. PubMed ID: 32502037
[TBL] [Abstract][Full Text] [Related]
22. Noninvasive models for the prediction of liver fibrosis in patients with chronic hepatitis B.
Wang J; Sun X; Wei S; Chen X; Zhu H; Liantang Y; Bao R; Du Y
BMC Gastroenterol; 2024 May; 24(1):183. PubMed ID: 38783185
[TBL] [Abstract][Full Text] [Related]
23. Gamma-glutamyl transpeptidase to platelet ratio index is a good noninvasive biomarker for predicting liver fibrosis in Chinese chronic hepatitis B patients.
Wang RQ; Zhang QS; Zhao SX; Niu XM; Du JH; Du HJ; Nan YM
J Int Med Res; 2016 Dec; 44(6):1302-1313. PubMed ID: 28322102
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic value of FIB-4, aspartate aminotransferase-to-platelet ratio index and liver stiffness measurement in hepatitis B virus-infected patients with persistently normal alanine aminotransferase.
Tan YW; Zhou XB; Ye Y; He C; Ge GH
World J Gastroenterol; 2017 Aug; 23(31):5746-5754. PubMed ID: 28883700
[TBL] [Abstract][Full Text] [Related]
25. The Easy Liver Fibrosis Test (eLIFT) for predicting advanced liver fibrosis in patients with chronic hepatitis B.
Wang J; Chen Z; Yan X; Yang Y; Liu Y; Chen Y; Jia B; Xia J; Xiong Y; Zhang Z; Ding W; Huang R; Wu C
Discov Med; 2019 Sep; 28(153):149-158. PubMed ID: 31926586
[TBL] [Abstract][Full Text] [Related]
26. Serum Gamma-Glutamyl Transpeptidase-to-Platelet Ratio as a Noninvasive Marker of Liver Fibrosis in Chronic Hepatitis B.
Purkayastha S; Jha AK; Kumar R; Dayal VM; Jha SK
Cureus; 2023 Jan; 15(1):e33744. PubMed ID: 36793825
[TBL] [Abstract][Full Text] [Related]
27. Accuracy of gamma-glutamyl transpeptidase-to-platelet ratio (GPR), red cell distribution width (RDW), aspartate aminotransferase-to-platelet ratio index (APRI), and the fibrosis-4 index (FIB4) compared with liver biopsy in patients with drug-induced liver injury (DILI).
Wan M; Xu H; Li D; Wang L; Li X
Medicine (Baltimore); 2021 Feb; 100(6):e24723. PubMed ID: 33578617
[TBL] [Abstract][Full Text] [Related]
28. Comparison and evaluation of non-invasive models in predicting liver inflammation and fibrosis of chronic hepatitis B virus-infected patients with high hepatitis B virus DNA and normal or mildly elevated alanine transaminase levels.
Wang L; Li J; Yang K; Zhang H; Wang Q; Lv X; Guan S
Medicine (Baltimore); 2020 Jun; 99(23):e20548. PubMed ID: 32502018
[TBL] [Abstract][Full Text] [Related]
29. The gamma-glutamyl transferase to platelet ratio for noninvasive evaluation of liver fibrosis in patients with primary biliary cholangitis.
Avcioğlu U; Eruzun H; Ustaoğlu M
Medicine (Baltimore); 2022 Oct; 101(40):e30626. PubMed ID: 36221370
[TBL] [Abstract][Full Text] [Related]
30. Noninvasive tests maintain high accuracy for advanced fibrosis in chronic hepatitis B patients with different nomenclatures of steatotic liver disease.
Chen L; Tao X; Zeng M; Li Y; Han J; Wang Y; Liu Y; Shi R; Su R; Xu L; Mi Y
J Med Virol; 2024 Apr; 96(4):e29613. PubMed ID: 38634477
[TBL] [Abstract][Full Text] [Related]
31. Application of alkaline phosphatase‑to‑platelet ratio as a novel noninvasive index predicts liver fibrosis in patients with chronic hepatitis B.
Pan Y; Yang K; Sun B; Chen J; Tian P
Exp Ther Med; 2022 Oct; 24(4):619. PubMed ID: 36160889
[TBL] [Abstract][Full Text] [Related]
32. Gamma-glutamyl transpeptidase-to-platelet ratio is an independent predictor of hepatitis B virus-related liver cancer.
Park YE; Kim BK; Park JY; Kim DY; Ahn SH; Han KH; Han S; Jeon MY; Heo JY; Song K; Kim SU
J Gastroenterol Hepatol; 2017 Jun; 32(6):1221-1229. PubMed ID: 27859587
[TBL] [Abstract][Full Text] [Related]
33. Simple noninvasive tests for liver fibrosis diagnosis in sub-Saharan African adults with chronic viral hepatitis B or C: A cross sectional study in Cameroon.
Edinga BEE; Bigna JJ; Nansseu JR; Tchapmi AY; Mbouna SFM; Belinga S; Njoya O; Ama-Moor VJ; Njouom R
Clin Chim Acta; 2022 Nov; 536():56-60. PubMed ID: 36155867
[TBL] [Abstract][Full Text] [Related]
34. [Value of non-invasive models of liver fibrosis in judgment of treatment timing in chronic hepatitis B patients with ALT < 2×upper limit of normal].
Zhou QQ; Hu YB; Zhou K; Zhang WW; Li MH; Dong P; Di JG; Hong L; Du QW; Xie Y; Sun QF
Zhonghua Gan Zang Bing Za Zhi; 2016 Sep; 24(9):665-670. PubMed ID: 27788722
[No Abstract] [Full Text] [Related]
35. [Diagnostic value of liver stiffness measurement for the evaluation of liver fibrosis in nonalcoholic fatty liver].
Ning J; Yao MJ; Liu SH; Zhou GD; Zhang Y; Li MY; Wang LJ; Wang L; Zhao JM; Lu FM
Zhonghua Gan Zang Bing Za Zhi; 2020 Jul; 28(7):567-572. PubMed ID: 32791791
[No Abstract] [Full Text] [Related]
36. The gamma-glutamyl transpeptidase-to-albumin ratio predicts significant fibrosis and cirrhosis in chronic hepatitis B patients.
Li Q; Lu C; Li W; Huang Y; Chen L
J Viral Hepat; 2017 Dec; 24(12):1143-1150. PubMed ID: 28685907
[TBL] [Abstract][Full Text] [Related]
37. GPR, King's Score and S-Index are superior to other non-invasive fibrosis markers in predicting the liver fibrosis in chronic Hepatitis B patients.
Ekin N; Ucmak F; Ebik B; Tugba Tuncel E; Kacmaz H; Arpa M; Engin Atay A
Acta Gastroenterol Belg; 2022; 85(1):62-68. PubMed ID: 35304995
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic thresholds and performance of noninvasive fibrosis scores are limited by age in patients with chronic hepatitis B.
Wang W; Zhao X; Li G; Wang L; Chen Y; Ma K; Chen G; Chen T; Han M; Ning Q; Zhao X
J Med Virol; 2019 Jul; 91(7):1279-1287. PubMed ID: 30788841
[TBL] [Abstract][Full Text] [Related]
39. Noninvasive diagnosis of significant liver inflammation in patients with chronic hepatitis B in the indeterminate phase.
Zhan J; Wang J; Zhang Z; Xue R; Jiang S; Liu J; Liu Y; Zhu L; Xia J; Yan X; Ding W; Zhu C; Qiu Y; Li J; Huang R; Wu C
Virulence; 2023 Dec; 14(1):2268497. PubMed ID: 37938933
[TBL] [Abstract][Full Text] [Related]
40. Effect of Concurrent Metabolic Dysfunction-Associated Steatotic Liver Disease on Serial Non-invasive Fibrosis Markers in Chronic Hepatitis B.
Con D; Tu S; Clayton-Chubb D; Lubel JS; Nicoll AJ; Sawhney R; Bloom S
Dig Dis Sci; 2024 Apr; 69(4):1496-1506. PubMed ID: 38376788
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
